Tyche Industries Limited
BSE: TYCHE
Prev Close
134.35
Open Price
135
Volume
1,530
Today Low / High
133.7 / 136
52 WK Low / High
129.1 / 200.85
Range
127 - 141
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 134.15, reflecting a change of -0.2 (-0.14886%). The expected target range on the BSE is 127 - 141. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Tyche Industries Limited Graph
Tyche Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Tyche Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 134.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 134.15 | 135.49 | 121.94 - 149.04 |
| 136.83 | 109.47 - 164.20 | ||
| 138.17 | 96.72 - 179.63 | ||
| Bearish Scenario | 134.15 | 132.81 | 119.53 - 146.09 |
| 131.47 | 105.17 - 157.76 | ||
| 130.13 | 91.09 - 169.16 |
Overview of Tyche Industries Limited
ISIN
INE443B01012
Industry
Medical - Pharmaceuticals
Vol.Avg
5,041
Market Cap
1,370,425,000
Last Dividend
2.5
Official Website
IPO Date
2000-11-29
DCF Diff
-119.78
DCF
254
Financial Ratios Every Investor Needs
Stock Dividend of TYCHE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-20 | September 20, 24 | 2.5 | 2.5 | 2024-09-20 | 2024-10-30 | |
| 2023-08-22 | August 22, 23 | 2 | 2 | 2023-08-22 | 2023-09-28 | |
| 2022-09-22 | September 22, 22 | 1.5 | 1.5 | 2022-09-23 | 2022-10-30 | |
| 2021-09-22 | September 22, 21 | 1 | 1 | 2021-09-23 | 2021-10-30 | |
| 2020-09-22 | September 22, 20 | 1 | 1 | 2020-09-23 | 2020-10-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 65.47 Cr | 36.42 Cr | 29.05 Cr | 0.4437 | 0.00 Cr | 0.00 Cr | 9.30 Cr | 12.41 Cr | 12.11 | 18.70 Cr | 0.1895 |
| 2024-03-31 | 69.51 Cr | 41.05 Cr | 28.46 Cr | 0.4094 | 0.98 Cr | 9.85 Cr | 11.12 Cr | 12.24 Cr | 11.95 | 18.57 Cr | 0.1761 |
| 2023-03-31 | 75.39 Cr | 52.11 Cr | 23.27 Cr | 0.3087 | 0.91 Cr | 2.36 Cr | 14.59 Cr | 14.17 Cr | 13.83 | 20.86 Cr | 0.1880 |
| 2022-03-31 | 62.27 Cr | 45.19 Cr | 17.08 Cr | 0.2743 | 0.67 Cr | 2.01 Cr | 9.90 Cr | 9.33 Cr | 9.11 | 11.71 Cr | 0.1499 |
| 2021-03-31 | 78.24 Cr | 39.53 Cr | 38.71 Cr | 0.4948 | 0.94 Cr | 1.87 Cr | 23.10 Cr | 19.98 Cr | 19.51 | 28.46 Cr | 0.2554 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 84.26 Cr | 147.41 Cr | 10.71 Cr | 136.7006 Cr | 0.00 Cr | -84.26 Cr | 16.64 Cr | 16.64 Cr | 0.00 Cr | 0.00 Cr | 9.69 Cr | 9.6247 Cr |
| 2024-03-31 | 3.97 Cr | 136.90 Cr | 10.16 Cr | 126.7351 Cr | 0.00 Cr | -3.97 Cr | 12.56 Cr | 17.90 Cr | 0.72 Cr | 0.00 Cr | 2.94 Cr | 6.6799 Cr |
| 2023-03-31 | 6.72 Cr | 136.72 Cr | 19.96 Cr | 116.7542 Cr | 0.00 Cr | -6.72 Cr | 18.05 Cr | 16.61 Cr | 1.50 Cr | 0.00 Cr | 3.30 Cr | 16.5727 Cr |
| 2022-03-31 | 3.59 Cr | 120.27 Cr | 16.05 Cr | 104.2190 Cr | 0.00 Cr | -3.59 Cr | 11.24 Cr | 16.63 Cr | 1.77 Cr | 0.00 Cr | 0.00 Cr | 12.8305 Cr |
| 2021-03-31 | 7.30 Cr | 116.95 Cr | 20.99 Cr | 95.9619 Cr | 0.00 Cr | -7.30 Cr | 10.95 Cr | 18.44 Cr | 0.93 Cr | 0.00 Cr | 0.00 Cr | 17.7915 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 8.5441 Cr | -0.6168 Cr | -2.5602 Cr | 7.8208 Cr | 0.0000 Cr | 84.2614 Cr | -0.7233 Cr | 12.4073 Cr | 0.0000 Cr | -2.5602 Cr | -4.0868 Cr |
| 2024-03-31 | 12.7671 Cr | 3.9434 Cr | -2.0481 Cr | 4.4824 Cr | 9.6100 Cr | 78.8944 Cr | -3.2324 Cr | 12.2430 Cr | 0.0000 Cr | -2.0481 Cr | 5.4135 Cr |
| 2023-03-31 | 6.4334 Cr | -3.1245 Cr | -1.5361 Cr | 4.6812 Cr | 1.7729 Cr | 69.2844 Cr | -1.7522 Cr | 18.9526 Cr | 0.0000 Cr | -1.5361 Cr | -6.7267 Cr |
| 2022-03-31 | 4.4602 Cr | 3.1568 Cr | -1.0241 Cr | 3.4695 Cr | 6.5929 Cr | 67.5115 Cr | -0.9907 Cr | 12.7282 Cr | 0.0000 Cr | -1.0241 Cr | -0.3492 Cr |
| 2021-03-31 | 15.4538 Cr | 0.4169 Cr | -1.0241 Cr | 12.9522 Cr | 14.8467 Cr | 60.9185 Cr | -2.5016 Cr | 26.5276 Cr | 0.0000 Cr | -1.0241 Cr | -1.3945 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.37 Cr | 8.03 Cr | 4.33 Cr | 0.3502 | -0.68 Cr | 0.94 Cr | 0.92 | 1.83 Cr | 0.0764 |
| 2024-12-31 | 17.75 Cr | 5.48 Cr | 12.27 Cr | 0.6913 | 4.34 Cr | 4.74 Cr | 4.63 | 6.88 Cr | 0.2672 |
| 2024-09-30 | 20.54 Cr | 7.78 Cr | 12.75 Cr | 0.6210 | 4.22 Cr | 3.99 Cr | 3.90 | 5.86 Cr | 0.1945 |
| 2024-06-30 | 15.52 Cr | 6.15 Cr | 9.37 Cr | 0.6035 | 2.12 Cr | 2.73 Cr | 2.66 | 4.14 Cr | 0.1756 |
| 2024-03-31 | 14.20 Cr | 7.95 Cr | 6.24 Cr | 0.4397 | 1.34 Cr | 2.10 Cr | 1.88 | 3.47 Cr | 0.1481 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 84.26 Cr | 0.00 Cr | 84.26 Cr | 17.12 Cr | 16.64 Cr | 120.94 Cr | 16.64 Cr | 147.41 Cr | 10.71 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 64.43 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -133.46 Cr |
| 2024-09-30 | 3.07 Cr | 61.36 Cr | 64.43 Cr | 28.67 Cr | 16.73 Cr | 111.44 Cr | 16.94 Cr | 148.29 Cr | 14.83 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 78.89 Cr | 0.00 Cr | 0.00 Cr | 78.89 Cr | 0.00 Cr | 0.00 Cr | -126.74 Cr |
| 2024-03-31 | 3.97 Cr | 71.80 Cr | 3.97 Cr | 21.01 Cr | 12.56 Cr | 113.05 Cr | 17.90 Cr | 136.90 Cr | 10.16 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 4.74 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 3.99 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 2.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 4.29 Cr | 0.96 Cr | 0.00 Cr | 0.00 Cr | 0.96 Cr | 74.03 Cr | 73.07 Cr | 0.00 Cr | 0.96 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1971
Gender: male
Year Born:
Gender: male
Year Born: 1983
FAQs about Tyche Industries Limited
The CEO is Ganesh Kumar Gokaraju.
The current price is ₹133.70.
The range is ₹129.1-200.85.
The market capitalization is ₹137.04 crores.
The dividend yield is 1.87%.
The P/E ratio is 11.04.
The company operates in the Healthcare sector.
Overview of Tyche Industries Limited (ISIN: INE443B01012) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹137.04 crores and an average daily volume of 5,041 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹2.5.